Society Committees

Education & Training Committee

This committee will enhance the availability and quality of training and education in metabolomics techniques to the global research community. It will help coordinate activities within the Metabolomics Society and engage and assist established training centers around the world. This will be achieved by:

  • Guiding the implementation of pedagogical best practice in training and education initiatives
  • Contributing educational and training content relevant to metabolomics
  • Enabling the exchange of ideas surrounding formal training and education in metabolomics.

Early-Career Members Network (EMN) Committee

The EMN aims to provide a forum for metabolomics researchers at the start of their professional career and serve the early-career members of the Metabolomics Society.  Aspirations include, but are not limited to: strengthen communication and collaboration, encourage opportunities and invention, support developmental learning and enjoy professional growth.

Membership Committee

The membership committee works to provide member services through the website and newsletters so that members are aware of the activities of the Society and can easily access the services that the Society makes available.

Nominations & Election Committee

Aurelia Williams

Aurelia Williams

North-West University
South Africa
Email

  • Chair – Conference Committee

Dr. Aurelia A. Williams is an Associate Professor of Biochemistry at North-West University (NWU), South Africa, and a researcher in the Biomedical and Molecular Metabolism Research Group (BioMMet). Her work focuses on uncovering small-molecule mechanisms underlying infectious and acquired diseases and developing innovative, translational strategies to improve health outcomes.

She completed her undergraduate and master’s studies at the University of Johannesburg and earned her PhD in Biochemistry from the University of Pretoria in 2012, with research on “Metabonomics Profile and Corresponding Immune Parameters of HIV-Infected Individuals.” She later undertook postdoctoral training at the University of California, San Francisco (UCSF), investigating genetic influences on brain tumour metabolism and growth.

Dr. Williams currently serves on the Board of Directors of the International Metabolomics Society, where she is Chair of the Conference Committee and a member of the Membership as well as Education and Training Committees. A prominent leader in South Africa’s scientific community, she is also the Deputy President and co-founder of Metabolomics South Africa (MSA), an organisation dedicated to promoting metabolomics research and collaboration. She chairs MSA’s Training and Conference Committee and previously served as Deputy Secretary (2018–2020).

Dr. Williams is facilitator for the Technological Higher Education Network South Africa (THENSA) under the Department of Science and Innovation, and an active member of several national and international scientific societies.

A passionate advocate for youth and women in science, she actively promotes the participation of young people—especially women—in science, technology, engineering, and mathematics (STEM) disciplines and careers.

Warwick "Rick" Dunn

Warwick “Rick” Dunn

University of Liverpool
UK
Email

  • Society President – Board of Directors
  • Co-Chair – Metabolite Identification Task Group
  • Co-Chair – Nominations & Elections Committee

Professor Warwick “Rick” Dunn holds a chair in Analytical and Clinical Metabolomics at the University of Liverpool. He obtained a lectureship in 2011 at the University of Manchester and moved to a lectureship at the University of Birmingham in 2013. He obtained a BSc(Hons) in Chemistry with Analytical Chemistry from the University of Hull and a PhD from the same university focused on developing interfaces to allow online monitoring of chemical process plants using mass spectrometry in association with BP Chemicals. He leads the Analytical and Clinical Metabolomics Group at the University of Liverpool. His research is focused on two areas (1) the development of new analytical tools and methods to enhance data quality, efficiency of metabolite annotation, coverage of detectable metabolites and sample collection strategies and (2) the application of untargeted and targeted metabolomics to the study of metabolism across the life course in humans including pre-birth, ageing, endocrinology, inflammatory and immune diseases and cancers with a focus on precision medicine. He was one of the founding coordinators of the metabolomics quality assurance and quality control consortium (www.mqacc.org). He was a board member of the society from 2010 to 2015 and now from 2022 to 2024. He sits on the Website and Communications committee, conference committee and education and training committee of the Metabolomics Society.  His career goals are to make metabolomics a standard resource applied in biological research and to train the next generation of metabolomics researchers.

María Eugenia Monge

María Eugenia Monge

CIBION – CONICET
Argentina
Email

  • Society Secretary –Board of Directors
  • Vice-Chair – Lipidomics Task Group
  • Vice-Chair – International Affiliations Task Group
  • Chair – Membership Committee

Dr. María Eugenia Monge is an Independent Researcher of the National Scientific and Technical Research Council of Argentina (CONICET) and works at the Centro de Investigaciones en Bionanociencias (CIBION). In 2006, she obtained her Ph.D. in analytical and physical chemistry from the University of Buenos Aires. Between 2007 and 2014, she held postdoctoral positions in Italy, France, and the USA. In 2014, she was recruited by CONICET to set up a new laboratory in a new research center in Argentina. At CIBION she leads the Bioanalytical Mass Spectrometry Group  and the Mass Spectrometry Facility. Her research group develops MS-based analytical methods using metabolomics and lipidomics approaches with applications in health, food and the environment. As well, her team has contributed with pipelines for preprocessing LC-MS and direct-to-MS data for quality control procedures in untargeted metabolomics workflows.  Since 2014, she has coordinated metabolomics courses for South American students and has participated in strengthening the Latin American scientific community through teaching in Brazil, Colombia, Mexico, and Argentina. Since 2021, she is a founding member of the Latin American Metabolic Profiling Society (LAMPS), and she has contributed to engage LAMPS as an international affiliate of the Metabolomics Society. Since 2019, she has been a member of the Metabolomics Society, where she currently serves as the Secretary, chair of the membership committee, vice-chair of the LipidMet Task Group and vice-chair of the International Affiliations Task Group. Since 2019, she has been a member of the metabolomics quality assurance and quality control consortium (mQACC). In 2022, she was awarded the Metabolomics Society Medal. Since 2025, she is an Executive Editor of Metabolomics.

Anne K Bendt

Anne K Bendt

Singapore Lipidomics Incubator
Singapore

  • Deputy Chair – Education & Training Committee

Dr. Anne K Bendt is Principal Investigator and Deputy Director at SLING, the Singapore Lipidomics Incubator, an internationally renowned R&D program in lipid research and technology development, anchored at the National University of Singapore. She focusses on the clinical translation of mass spectrometry-based technologies into ‘real life’ applications, primarily for lipids and small molecules. Realizing the importance of strict quality control particularly for clinical applications, Anne recently spearheaded the implementation of mass spec-based workflows for a steroid panel compliant with ISO15189, the international standard for medical diagnostics.

Anne is further passionate about training and education, and has made substantial contributions to SLING’s various workshops and ‘ic lipid’ training courses. Internationally, Anne is co-instructor of ‘Lipidomics 101’, a short course for clinical lipidomics.

With clinical translation close to her heart, Anne serves on the ‘Metabolomics’ working group within the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). She further serves on the steering committee of ‘Clinical Lipidomics’ within the International Lipidomics Society (ILS) and as Associate Editor for ‘Journal of Mass Spectrometry and Advances in the Clinical Lab’ (JMSACL). In 2025, Anne was elected to the Board of Directors of the Metabolomics Society. Early 2019 Anne co-founded the global initiative ‘Females in Mass Spectrometry’ (FeMS), serving as Chair on the Board.

Mónica Cala

Mónica Cala

Universidad de los Andes
Columbia

Biography:

Dr. Mónica Cala is the Head of MetCore, the first Metabolomics Core Facility in Colombia, based at Universidad de los Andes, and a founding member of the Latin American Metabolic Profiling Society (LAMPS). She has over 15 years of experience in bioanalytical applications, with a strong background in developing and validating analytical methods using separation techniques and spectrometric analysis.

Since 2012, her work has focused on applying high-resolution mass spectrometry-based metabolomics and lipidomics to a range of research areas, including biomedicine, plant science, and food analysis. In 2019, she established MetCore under the Vice Presidency for Research at Uniandes, marking a milestone as the first Metabolomics Center in the country. Since then, she has played an active role in raising awareness and advancing metabolomics research in Colombia and across Latin America.

In 2023, she received the President’s Award from the International Metabolomics Society. In 2024, Dr. Cala was recognized as one of 18 featured scientists in C&EN Trailblazers, which highlights Latin American chemists making a significant impact in the region, selected from 150 nominated profiles submitted by readers.

At MetCore, Dr. Cala leads research projects using both non-targeted and targeted metabolomics approaches in fields such as biomedicine, bioprospecting, and food science. The facility is committed to providing access to cutting-edge mass spectrometry platforms, including GC-MS, CE-MS, and UHPLC-MS, and to promoting innovative, multidisciplinary research and services in Colombia and throughout Latin America.

Statement of Purpose:

If elected, I would be honored to contribute to the Conference and International Affiliates Committees and to continue building stronger connections between Latin America and the global metabolomics community. With the 2026 Metabolomics Society Congress taking place in Latin America for the first time,and as a co-chair of this event,I feel especially motivated to help increase the participation of researchers from our region. I would also like to support greater involvement of young Latin American scientists in the Early-career Members Network (EMN), and help strengthen the visibility and engagement of our community in global metabolomics initiatives.

Since founding MetCore, I have been committed to promoting metabolomics in Colombia and across Latin America. Through MetCore’s training activities, I have helped connect students and researchers from several Latin American countries, including those with limited previous participation in the Latin American Metabolic Profiling Society (LAMPS), such as Chile, Peru, Ecuador, Costa Rica, Guatemala, and Mexico. As a founding member of LAMPS, I supported the integration of our network into the Metabolomics Society’s International Affiliates. In 2022, I organized the IV LAMPS Meeting in Cartagena, Colombia, which brought together over 100 participants and helped strengthen regional ties.

I look forward to contributing to the Society’s mission and to amplifying the voices, talent, and ideas from Latin America within the global metabolomics community.

Breanna Dixon

Breanna Dixon

University of Manchester
UK
Email

  • Chair – EMN Committee

After recently submitting her PhD at the University of Manchester, United Kingdom, where she applied metabolomics to investigate signatures of antibiotic resistance for improved diagnostics, Breanna is moving into a postdoctoral position focused on biomarkers of Parkinson’s disease and the investigation of novel therapeutic efficacy. Breanna holds an MSc in Forensic and Analytical Science from Kingston University London, United Kingdom, and a BSc in Biochemistry & Molecular Biology and Neuroscience from the University of Western Australia. She also brings industry experience, having worked in pharmaceutical R&D as an analytical chemist. Her research interests lie at the intersection of clinical metabolomics and translational medicine, with a particular focus on biomarker discovery and therapeutic development. Beyond research, Breanna is passionate about inclusivity and representation in science and is an active member of committees across several organisations dedicated to these aims.

Roy Goodacre

Roy Goodacre

University of Liverpool
UK

  • Immediate Past President – Board of Directors
  • Chair – Nominations & Elections Committee

Roy Goodacre is Professor of Biological Chemistry at the University of Liverpool and a co-director of the Centre for Metabolomics Research.  He helped to develop and establish long-term metabolomics which allows fusion of GC-MS and LC-MS data.  These approaches have been used by his team and collaborators to profile health populations and investigate the frailty phenotype during the ageing process.

Trained as a microbiologist in Bristol, UK, he has a fascination with the microbial world.  Thus, in parallel, in order to understand metabolic flux on a single cell level for bacterial community analysis, his group are currently developing high spatial resolution photothermal infrared and Raman-based imaging methods which can be used to generate chemical images of microbial cells.  Please see the wiki for more details.

Roy has published a substantial number of primary papers and reviews in metabolomics and data processing as well as Raman Spectroscopy, and if you like such metrics he has a H-index of over 100.

Outside of metabolomics, Roy is a proud Welshman and avid rugby supporter.  He is fascinated by the lunar landscape of Lanzarote and visits with the family as often as he can, where he loves to walk and visit the many charms that this volcanic island has to offer.

Kyo Bin Kang

Kyo Bin Kang

Sookmyung Women’s University
Republic of Korea

  • Co-Chair – Website & Communications Committee

Kyo Bin Kang is an Associate Professor at the College of Pharmacy, Sookmyung Women’s University in Seoul, Korea. Since establishing his lab in 2018, he has focused on applying computational mass spectrometry-based metabolomics to study specialized metabolites produced by bacteria, fungi, and plants. Trained as a natural product chemist, he completed his PhD at Seoul National University in 2016, concentrating on the purification and structural elucidation of phytochemicals. During his first postdoctoral research at the same institution, he developed a strong interest in mass spectrometry-based metabolomics as a powerful tool in natural product discovery. To deepen his expertise, he joined the Dorrestein Lab at UC San Diego for his second postdoctoral training, where he became a devoted proponent of computational mass spectrometry and open science.

His lab now investigates not only the discovery of novel or bioactive compounds, but also the ecological and biochemical logic behind the chemical diversity of natural products—how and why they are biosynthesized, and how organisms biotransform and detoxify foreign molecules. Metabolomics is central to generating hypotheses across all these research directions.

Kyo Bin is also actively engaged in infrastructure development for the Korea MetAbolomics data repository (KMAP), striving to align it with the FAIR principles and harmonize it with other global repositories.

Julia Kuligowski

Julia Kuligowski

Health Research Institute La Fe
Spain

  • Chair – Publications Committee

Dr. Julia Kuligowski is a senior researcher at the Neonatal Research Group of the Health Research Institute La Fe in Valencia, Spain. She is an internationally recognized expert in metabolomics, with a research focus on neonatal health and nutrition. At IISLaFe, she leads a multidisciplinary team advancing the clinical applications of mass spectrometry-based metabolomics. Her work explores early biomarkers for neonatal encephalopathy, the impact of maternal and donor human milk, and the characterization of extracellular vesicles. She also develops translational tools, such as point-of-care sensors and rapid screening methods, bridging the gap between laboratory discovery and clinical practice.

As a dedicated mentor, Dr. Kuligowski supervises undergraduate, master’s, and PhD students and teaches regularly at the University of Valencia. She is an active member of the international metabolomics and extracellular vesicle communities, contributing to initiatives including the Metabolomics Quality Assurance and Quality Control Consortium, the ISEV Milk Task Force, and the Metabolomics Society’s Board of Directors and Lipidomics Task Group. She has also served on the organizing committees for several Metabolomics Society Annual Meetings and has taken on leadership roles within the COST Action EpiLipidNet.

Passionate about scientific communication and outreach, Julia is committed to fostering collaboration, promoting rigorous and standardized science, and sharing the value of research with the wider community. She regularly participates in dissemination initiatives promoting breastfeeding and natural lactation, as well as interactive science workshops for children and families.

Tomáš Pluskal

Tomáš Pluskal

Czech Academy of Sciences
Czech Republic

I am a Junior Group Leader at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences in Prague. My laboratory develops new computational and experimental approaches for connecting plant natural products to their biosynthetic enzymes, and for engineering novel biosynthetic circuits using synthetic biology tools. Presently I am supervising 4 Ph.D. students and 4 postdocs with both computational and experimental expertise. I myself have an interdisciplinary background in computer science (MSc) and molecular biotechnology (Ph.D.). I first started working in metabolomics in 2006 during my PhD in Japan, where I developed the complete workflows for LC-MS analyses of fission yeast (Schizosaccharomyces pombe). At the same time, I started developing the MZmine software for mass spectrometry data processing, which has become one of my signature projects. During my postdoc at the Whitehead Institute (MIT) in the U.S., I studied the biosynthesis of psychoactive molecules in the kava plant (Piper methysticum). I am fascinated by the complex chemistry and molecular interactions that we can observe in nature, and in my own lab I am trying to apply diverse approaches to address this complexity.

Silvia Radenkovic

Silvia Radenkovic

University Medical Center (UMC) Utrecht
The Netherlands
Email

  • Ex-offico, EMN Chair

After earning her PhD at the Metabolomics Expertise Center, KU Leuven Faculty of Medicine, Leuven, Belgium, and Mayo Clinic (visiting), Silvia completed her research fellowship at the Mayo Clinic Department of Clinical Genomics. She was also a part of the undiagnosed disease network (UDN) Mayo Clinic metabolomics core, whose focus was to help find diagnoses for undiagnosed patients using metabolomics. Currently, she is pursuing medical training in laboratory clinical genetics at University Medical Center (UMC) Utrecht, the Netherlands. Silvia’s research focuses on inborn errors of metabolism, like congenital disorders of glycosylation (CDG). Specifically, she is interested in the metabolic rewiring in CDGs focusing on the heart and brain. She holds expertise in laboratory clinical genetics, different omics techniques such as tracer metabolomics, and different disease models (e.g., patient fibroblasts, induced pluripotent stem cells (iPSC), iPSC-derived brain organoids, iPSC-derived Cardiomyocytes, zebrafish). Finally, she is passionate about research, mentoring, teaching, and scientific communication and she is part of several initiatives for early career researchers including the EMN Metabolomics Society, Biochemical Society and Females in Mass-Spectrometry.

Lynn Vanhaecke

Lynn Vanhaecke

Ghent University
Belgium
Email

  • Chair – Website & Communication Committee

Lynn Vanhaecke is a Professor at the Laboratory of Integrative Metabolomics (LIMET) at Ghent University, Belgium since 2011 with a 20% appointment at the Institute of Global Food Security at Queen’s University Belfast, UK since 2018. She holds a Ph.D. in Bioscience Engineering (2008) on gut microbial food metabolism. 

Her team has specific expertise in optimizing and validating high-resolution mass spectrometry (HRMS)-based metabolomics and lipidomics methods with a focus on gastrointestinal matrices (saliva, stool, in vitro digests) and uses the latter to explore metabolic pathways of food- and gut microbiome-related diseases ranging from food allergies to obesity and its comorbidities. She is also particularly interested in the application of ambient ionization-based HRMS (specifically REIMS) for biofluid and food metabolomics and invented the MetaSamp® biofluid sampler in this context. 

Lynn’s lab has pioneered the field of DNA adductomics in the EU by developing a high-end analytical UHPLC-HRMS platform for untargeted DNA adduct measurements. In recent years, her lab has also gained an interest in the computational part of the metabolomics workflow with dedicated bioinformaticians on staff. Lynn is coordinator of the core facility on small molecule analysis (MSsmall) at Ghent University and a board member of the Nutrigenomics Society (NuGO). 

She was involved in the Horizon 2020 JPI-HDHL Foodball project and two EIT Food projects on food metabolomics and is now a core partner of the first Flemish Exposome project (Flexigut). LIMET’s metabolomics workflows have been sublicensed to Prodigest under the brand name MetaKey® for commercial application.

Nicholas J.W. Rattray

Nicholas J. W. Rattray

University of Strathclyde
UK
Email

  • Chair – Education & Training Committee

Nicholas (Nik) Rattray is Professor of Clinical Metabolism at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where he also serves as Director of the Strathclyde Centre for Molecular Bioscience. He earned his PhD in Biophysics from the University of Manchester and completed postdoctoral research at the Manchester Institute of Biotechnology, applying mass spectrometry-based metabolomics to investigate the biochemistry of frailty. He later held a faculty-level Associate Research Scientist position at the Yale School of Public Health, focusing on metabolomics in large-scale population studies. He currently holds a Royal Society Industry Fellowship on Surgical Frailty and is a Fellow of the Higher Education Academy.

Nik’s research group at Strathclyde explores how metabolic pathways become dysregulated with age, with a particular emphasis on predictive metabolic and protein biomarkers of surgical response. His research is structured around three interconnected themes:

  • Biomolecular Target Development: Employing advanced metabolomics, proteomics, stable isotope tracers, and cell-based assays to identify biomarkers associated with senescence, age-related diseases, and frailty.
  • Clinical Translation: Designing and conducting clinical trials to assess mitochondrial biomarkers as predictors of surgical outcomes in frail and diseased patients.
  • Biobank-Driven Insights: Applying AI and deep learning to multiomics datasets (e.g., UK Biobank) to examine how biomolecular, clinical, and socioeconomic factors interact in the context of frailty.

This multidisciplinary approach is also being applied to diseases such as breast cancer, colon cancer, oropharyngeal cancer, and inflammatory bowel disease. Nik’s overarching goal is to define the biomolecular basis of ageing and establish global leadership in the metabolism of frailty, transforming clinical and societal perspectives on ageing through translational science.

Ambrin Farizah Babu

Ambrin Farizah Babu

University of Turku
Finland

Dr. Ambrin Farizah Babu is a TCSMT Postdoctoral Research Fellow at the University of Turku and a Scientist at Afekta Technologies Ltd. She earned her PhD in Nutrition Science from the University of Eastern Finland as part of the Marie Curie ITN. Her doctoral research applied non-targeted LC–MS metabolomics to investigate metabolic dysfunction-associated steatotic liver disease (MASLD), focusing on the effects of lifestyle interventions and novel microbiome-targeted therapeutics in both human and murine models.

Her current research builds on this foundation, integrating multi-omics datasets to elucidate how dietary patterns and microbial metabolism influence host metabolic health. With international research experience spanning India, Switzerland, Germany, and Finland, Dr. Babu combines academic insight with translational and industry-oriented metabolomics expertise.

Beyond her scientific work, she is deeply committed to mentorship, community building, and contributes to initiatives supporting early-career researchers. Her broader vision is to translate insights from diet–microbiome–host interaction into actionable solutions for improving metabolic health and disease prevention.

Sofina Begum

Sofina Begum (Society Secretary)

Harvard University
USA

Dr. Sofina Begum is currently a Senior Research Operations Program Manager at Harvard Medical School and Mass General Brigham. She was awarded a Medical Research Council (MRC) fellowship, completing her PhD at Imperial College London in 2021, focused on Bioinformatics and Integrative Metabonomics. For her doctoral work, Dr. Begum was awarded the Rosalind Franklin Clinical Metabolomics Award in 2022 from Females in Mass Spectrometry (FEMS). In her post-doctoral research at Harvard Medical School, Dr. Begum’s research focused on large-scale metabolomic applications on biobank populations, integrated with dynamic health data. Dr. Begum currently holds honorary fellowships at both Imperial College London and the University of Western Australia, in addition to being a member of the editorial board for the journal Frontiers in Public Health.

Dr. Begum’s expertise within metabolomics and multi-omics on an international level, has enabled her to bridge the gap between benchtop and data scientists, and has proved to be vastly beneficial in the development of precision medicine research strategies. In her current research, she manages a nationwide NIH-funded initiative in the United States, driving strategic operational development and deployment of multi-omics for clinical research studies.

President Award winner Dr. Evelina Charidemou

Evelina Charidemou, PhD

University of Nicosia
Cyprus

Dr. Evelina Charidemou is an Assistant Professor at the University of Nicosia. She graduated with first-class honours in Biochemistry from Imperial College London and completed her PhD in 2019 at the University of Cambridge in Professor Julian Griffin’s group. Her doctoral research linked specific amino acids to insulin resistance via de novo lipogenesis, using advanced metabolomic and bioinformatic techniques. In 2019, Dr. Charidemou was awarded a prestigious Marie Skłodowska-Curie Individual Fellowship. During this fellowship, she combined metabolomic and epigenomic approaches to study metabolic changes caused by epigenetic modifiers at the University of Cyprus. She has presented her work internationally and published in leading scientific journals.

Dr. Charidemou has developed innovative methodologies integrating molecular biology, biochemistry, and computational tools to investigate the interface between epigenetics and metabolism. She is an active member of the metabolomics research community, having chaired the Early Career Members Network of the Metabolomics Society (2021–2023) and founded the Cyprus Metabolomics Network to promote the field both locally and globally. In recognition of her contributions to the field, she was awarded the 2024 President’s Award of the Metabolomics Society, an honour given for excellence in research within the first 5–10 years of an independent career. In the same year, she also received the Cyprus Young Researcher Award in Life Sciences, further acknowledging her impactful research trajectory.

Su H. Chu

Su H. Chu

Harvard University
USA

Dr. Su H. Chu is an Assistant Professor at Harvard Medical School (HMS) and an associate statistician at the Brigham and Women’s Hospital. A biostatistician and molecular epidemiologist by training, she has developed novel methods for integrative multiomic gene set analysis, and led one of the first epigenome-wide applications of mediation analysis. Dr. Chu serves as the Chair of the Statistics Working Group for the Consortium of Metabolomics Studies (COMETS) and served on the COMETS Executive Steering Committee (2022-2025). Dr. Chu is deeply committed to pedagogy and training of students and postdoctoral fellows and has taught at local, national, and international levels. She is a Director for core courses for the Master of Medical Sciences in Clinical Investigation and the Master of Science in Clinical Research degrees at HMS. She has also taught a Harvard Catalyst continuing education short course on metabolomics, and has served as a Co-Director for the international Global Clinical Research Scholars certificate program offered by the Harvard Office of External Education. Her research interests include novel applications of causal inference methods in metabolomic epidemiology, with an emphasis on early/developmental social and environmental determinants of respiratory disease across the life course.

Prof. Tim Ebbels

Timothy Ebbels

Imperial College London
UK

Prof. Tim Ebbels was awarded his PhD in 1998 from the University of Cambridge. His group focuses on the application of bioinformatic, machine learning and chemometric techniques to post-genomic data, with a particular emphasis on computational metabolomics. Key areas of interest are NMR & MS data processing, data integration, visualisation, network analysis, time series and metabolite annotation. He is particularly known for the ‘BATMAN’ software for analysing complex metabolic NMR spectra, and more recently his work using biological pathways to build interpretable models of metabolomics data. Tim is a previous Director of the international Metabolomics Society and a co-founder of the London Metabolomics Network. He has supported numerous efforts promoting quality and reusability of metabolomics data and is an editorial board member for BMC Bioinformatics. He has a strong commitment to education, serving as Director of the MRes in Biomedical Research at Imperial College (>1000 students trained) and leading Imperial’s Data Analysis in Metabolomics short course. He is a Fellow of the Royal Society of Chemistry and Lifetime Honorary Fellow of the Metabolomics Society.

Álvaro Fernández Ochoa

Álvaro Fernández Ochoa

University of Granada
Spain

Dr. Álvaro Fernández Ochoa holds a prestigious Ramón y Cajal tenure-track research fellowship at the University of Granada (UGR, Spain). He earned his degree in Chemistry from the University of La Rioja in 2014 and completed his PhD at UGR between 2015 and 2019. From 2020 to 2022, he worked as a postdoctoral researcher at the Metabolomics Platform of the Max Delbrück Center for Molecular Medicine (Berlin, Germany). Since 2022, he has continued his research at UGR through various postdoctoral grants.

Throughout his scientific career, Dr. Fernández Ochoa has focused on developing untargeted metabolomics methodologies based on high-resolution mass spectrometry, with applications in both clinical and dietary intervention studies. He has participated in ten competitively funded research projects, and co-authored 50 JCR-indexed publications and eight book chapters.

He has taught official courses at UGR and delivered international online courses (Brazil, Costa Rica, Argentina) to promote the transfer of metabolomics knowledge. He has supervised 20 Master’s Theses and 10 Bachelor’s Theses and is currently supervising three doctoral dissertations. He is an active member of several scientific societies (Metabolomics Society, mQACC, SESMet, and Groupe Polyphenols) and has played a key role in organizing scientific conferences and public science dissemination activities.

Natasa Giallourou

Natasa Giallourou

Metabolon
Cyprus

  • Co-Chair – Industry Engagement Task Group

Natasa Giallourou, PhD, is a Field Metabolomics Specialist at Metabolon (USA), where she provides scientific support for metabolomics applications across the biopharma and academic sectors.

Before joining Metabolon, Natasa was a Marie Skłodowska-Curie Postdoctoral Fellow at biobank.cy, leading projects that integrated metabolomic and multi-omics data in population-based studies to identify biomarkers of complex diseases. Earlier, she worked as a Postdoctoral Research Associate at Imperial College London, applying metabolic phenotyping to global health challenges with a focus on public health nutrition.

She earned her PhD in Nutritional Metabolomics from the University of Reading in 2017, following an MSc in Nutrition and Health from Wageningen University and a BSc in Biology from the University of Leeds.
From 2020 to 2025, she served on the Board of Directors of the Metabolomics Society and currently contributes to its Education and Training Committee.

Purva Kulkarni

Purva Kulkarni

Radboud University Medical Center
Netherlands

Dr. Purva Kulkarni is a bioinformatics scientist leading the computational metabolomics projects at the Translational Metabolic Laboratory (TML), Department of Human Genetics, Radboud University Medical Center in Nijmegen, The Netherlands. She received her PhD in Bioinformatics from the Max Planck Institute of Chemical Ecology and Friedrich Schiller University in Jena, Germany in September 2018. During her doctoral research, she developed innovative computational algorithms to analyze mass spectrometry (MS) imaging data, laying a strong foundation for her expertise in computational metabolomics data analysis. Following her PhD, Dr. Kulkarni joined the Netherlands Institute of Ecology in Wageningen for her first postdoctoral research position. During her time there, she successfully established computational workflows for untargeted metabolomics data, focusing on gas chromatography MS and imaging MS experiments.

At the core of Dr. Kulkarni’s research is a passion for leveraging bioinformatics, machine learning, and computational analysis to interpret metabolomics data for clinical translation. Currently, at TML, her research centers on developing robust algorithms and computational workflows to identify disease-related molecular signatures from untargeted metabolomics and glycoproteomics data. These efforts have direct implications for personalized diagnostics, particularly for rare metabolic diseases. Her leadership extends beyond the lab, as she actively contributes to major national initiatives such as the Netherlands X-omics initiative and the United for Metabolic Diseases (UMD) consortium, collaborating to advance omics research and its applications in rare disease research.

Aleš Kvasnička

Aleš Kvasnička

Oslo University Hospital
Finland

Dr. Aleš Kvasnička is a Clinical Metabolomics Scientist at the Section for Metabolomics and Lipidomics at Oslo University Hospital, Norway, working in the team of Katja B. P. Elgstøen. In parallel, he is employed as a researcher at the Core Facility for Global Metabolomics and Lipidomics at the University of Oslo. During his PhD in Clinical Biochemistry (Faculty of Medicine, Palacký University, Czechia, 2024), he completed several international internships at leading research laboratories in Germany, Norway, and Japan. The primary focus of his research lies in the clinical application of metabolomics and lipidomics, with a particular emphasis on their translation into medical practice. He is actively involved in several scientific and professional societies, including the Metabolomics Society (past EMN member and current ETC committee member), EFLM (Chair of the YS Committee), and the IFCC (member of the Metabolomics WG). Moreover, he serves as a member of the Editorial Advisory Board of the Metabolomics journal. In the field of education, he has contributed to the development of best practice guidelines for statistical processing and visualisation of metabolomics and lipidomics data, and he is a coordinator of the EFLM Syllabus Module on Clinical Mass Spectrometry.

Alice Limonciel

Alice Limonciel

Biocrates
Austria

Loic Mervant

Loic Mervant

The Francis Crick Institute
UK

Loic is a post-doctoral researcher at The Francis Crick Institute (London) in Karen Vousden lab where he’s using metabolomics and proteomics to better understand the metastasis process in pancreatic cancer and more precisely the implementation of the pre-metastatic niche, one of the key features for successful metastasis. He holds a PhD from Toulouse University (France) in Metabolomics and Toxicology where his research focused on the impact of high red meat diet on the promotion of colorectal cancer. After his MSc in Metabolomics and Proteomics obtained from Toulouse University and before embarking on an academic journey, Loic worked for two years as a metabolomics scientist in a pharma company, working on the discovery of biomarkers for neurodegenerative diseases such as SLA or MS. Loic is also involved in the French metabolomics network as a junior member since 2019 and now joining the EMN with the hope to contribute the international metabolomics community.

Louis-Feliz Nothias

Louis-Felix Nothias

University Côte d’Azur
France

Dr. Louis-Félix Nothias is a CNRS junior group leader based at the University Côte d’Azur & the Interdisciplinary Institute for Artificial Intelligence Côte d’Azur, France. In 2023, he founded the Holobiomics Lab, which develops experimental and computational methods for studying host/microbial metabolism in holobionts and their microbiomes. The lab is engineering advanced mass spectrometry-based metabolomics techniques in multi-omics studies using artificial intelligence. Prior to this, Dr. Nothias was a postdoctoral researcher at the University of California San Diego with Prof. Pieter Dorrestein, where he contributed to the GNPS ecosystem (2016-2021), and a research associate at the University of Geneva with Prof. Jean-Luc Wolfender (2021-2023). He has contributed to computational methods for MS-based metabolomics annotation (see CASMI 2023 in collaboration with the SIRIUS team/Boecker lab) and has pioneered integrative multi-omics studies for studying microbiota metabolites in ecosystems, including through the collaborative Earth Microbiome Project.

Susana Alejandra Palma Duran

Susana Alejandra Palma Diram

Research Center in Food and Development
México

Susana Palma is an associate professor at the Research Center in Food and Development –CIAD (México), where she focuses on the metabolic changes associated with environmental and dietary factors, the relationship of those changes with chronic diseases, and the investigation of solutions for disease prevention. With her analytical experience, she develops mass spectrometry and chromatographic (LC, SFC & GC) methods for detecting metabolites, lipids, bioactives, and contaminants (including pesticides) in biological, cellular, food, and environmental samples. At CIAD, she supervises undergraduate, master’s, and PhD students on the application of metabolomics in food science and nutrition. Furthermore, she enjoys contributing to the community as a member of the Metabolomics Society (Membership, Education, and Training Committee, former EMN member) and the Metabolomics Association of North America (MANA), as well as teaching metabolomics at both the undergraduate and postgraduate levels. Additionally, she serves as Associate Editor of the European Journal of Clinical Nutrition. Prior to this, she has investigated biomarkers of sugar intake (Arizona State University) and examined metabolomic phenotypes associated with obesity (University of Cambridge and Imperial College London). She has also worked at the Francis Crick Institute, applying metabolomics and lipidomics approaches to understand, diagnose, and treat various diseases. Susana holds a BSc in Clinical Biochemistry (University of Sonora, Mexico), an MSc in Food Science (CIAD, Mexico), and a PhD in Human Nutrition (University of Glasgow, UK).

Lucas Pradi

Lucas Pradi

University Côte d’Azur
France

Lucas Pradi is a PhD candidate in Analytical Chemistry at the Université Côte d’Azur, working within the Molecular Diversity, Metabolomics and Synthesis Team at the Institut de Chimie de Nice under the supervision of Dr. Louis Félix Nothias. His project, funded by the Luxembourg National Research Fund (FNR), focuses on developing next-generation untargeted mass spectrometry-based metabolomics acquisition strategies and computational frameworks for improved high quality fragmentation coverage.

He holds a Master’s degree in Organic Chemistry and a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (Brazil). His background spans from natural products chemistry, analytical chemistry, to computational metabolomics, combining expertise in LC-MS/MS, data analysis, and AI-driven methods.

Lucas’s research integrates artificial intelligence and large language models (LLMs) with metabolomics workflows, aiming to accelerate scientific discovery and improve data interpretation. multidisciplinary approach bridging analytical chemistry, computational science, and natural product research toward more efficient, data-driven metabolomics.

Stacey Reinke

Stacey Reinke

Edith Cowan University
Australia

Stacey Reinke is a Senior Lecturer in Applied Statistics and Computational Biology at Edith Cowan University (Perth, Australia). She completed her PhD in Biochemistry at the University of Alberta (Canada) in 2011. Her early research investigated mitochondrial dysfunction in model systems, which expanded to investigating energy metabolism dysregulation in inflammatory diseases in her first postdoctoral position. During this time, Stacey worked closely with David Broadhurst which fostered her interest in design of experiments, statistics, and data science.

Upon receiving a Canadian Institutes of Health Research Fellowship in 2014, Stacey relocated to the Karolinska Institute (Sweden) where she worked under the mentorship of Craig Wheelock. Here, she played a key role in developing large-scale clinical metabolomics workflows for as part of the EU-wide UBIOPRED asthma project. In 2016, Stacey was recruited to Perth (Australia) as part of a state-led initiative to enhance clinical metabolomics capacity in Western Australia.

Stacey’s applied research primarily focusses on using metabolomics to investigate the underlying mechanisms of respiratory diseases. As a teaching-research scholar and biochemist turned computational biologist, Stacey is also passionate about improving data literacy for biologists. This is reflected in her methodological papers and her involvement in the Society’s Education & Training Committee.

Jayden Lee Roberts

Jayden Lee Roberts

Murdoch University
Australia

  • Secretary – EMN Committee

Jayden completed his PhD in 2025 at the Australian National Phenome Centre (ANPC) – Murdoch University, Western Australia. His research centers on sample miniaturization in metabolic phenotyping, specifically utilizing dried blood spot (DBS) microsamples. Jayden aims to make metabolic profiling more patient-centric and accessible, particularly for underserved populations in remote or resource-limited settings, where traditional blood sampling methods often create significant barriers due to logistical challenges and limited healthcare access. He employs a combination of targeted and untargeted LC-MS (TQ, timsTOF) and proton NMR spectroscopy in his analyses. Jayden also lectures in biochemistry, immunology, and infectious diseases at the University of Notre Dame Australia and is a member of the ECR subcommittee of the Australian and New Zealand Metabolomics Society.

Monique Ryan

Monique J Ryan

Murdoch University
Australia

Dr. Monique J Ryan is a postdoctoral researcher at the Australian National Phenome Centre (ANPC) and Centre for Computational and Systems Medicine (CCSM), Murdoch University, with expertise in clinical metabolomics, lipidomics and mass spectrometry. Dr. Ryan completed a PhD in Medical, Molecular and Forensic Sciences, investigating metabolic phenotypes in burn wound healing to improve diagnostic and therapeutic strategies in inflammatory injury in adults.

Her postdoctoral research has since expanded to explore the long-term metabolic consequences of burn injury in children, with a focus on systemic inflammation, lipid metabolism and stress regulation. This work utilises lipidomics to uncover markers relevant to recovery and resilience in paediatric populations.

Dr. Ryan’s skillset spans experimental design, clinical sample handling, advanced mass spectrometry and data interpretation. She is also actively engaged in education and training, coordinating workshops at ANPC and supporting early-career researchers through committee roles with the Metabolomics Society and the Australian and New Zealand Metabolomics Society.

With a foundation in biomedical science and translational metabolomics, Dr. Ryan is committed to advancing clinical applications of metabolomics and lipidomics and promoting inclusive, high-impact training environments for the next generation of researchers.

Generic Person Place Holder

Denise Slenter

Maastricht University
Netherlands

Jan Stanstrup

Jan Stanstrup

University of Copenhagen
Denmark

Jan Stanstrup is an Assistant Professor at the Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark. His research focuses on computational and applied metabolomics, particularly in the context of human nutrition and metabolism. Bridging analytical chemistry and bioinformatics, he develops open-source tools and workflows that enhance data quality, reproducibility, and transparency in metabolomics research.

Jan is the creator of PredRet, a community-driven platform for predicting and mapping chromatographic retention times across systems, and a contributor to central R packages in the metabolomics community. His recent work includes developing approaches for automated quality control and spectral library curation, supporting the implementation of FAIR data principles across nutrition and metabolomics studies.

He teaches metabolomics at the master’s level and runs a PhD course in metabolomics, emphasizing reproducible analysis and practical data interpretation. Having worked in clinical, agricultural, and nutritional research environments, Jan brings a broad, cross-disciplinary perspective to the application and development of metabolomics methodologies.

Dakshat Trivedi

Dakshat Trivedi

University of Southampton
UK

Dr Dakshat Trivedi is an aspiring early-career clinical metabolomics researcher at the University of Southampton (UK), where he is a ResDakshat is a Research Fellow in Clinical Metabolomics at the NIHR Southampton Biomedical Research Centre, University of Southampton, UK. He holds a PhD in metabolomics and biological chemistry from the Manchester Institute of Biotechnology at the University of Manchester. He completed postdoctoral research at the Centre for Metabolomics Research (University of Liverpool) and the Clinical Metabolomics Unit (University of Southampton) before being awarded an NIHR Biomedical Research Centre postdoctoral fellowship at University of Southampton, UK.

Dakshat’s research focuses on translating metabolic alterations into clinical insight — linking metabolic fingerprints with symptoms, outcomes, and patient trajectories. He applies clinical mass spectrometry (LC-MS and GC-MS) to patient cohorts to understand metabolic dysregulation across the clinical pathway, from early disease detection to treatment response and recovery. His goal is to move metabolomics beyond discovery and toward clinical implementation, where metabolic profiles support personalised medicine, patient stratification, and risk prediction. His active domains of interest include ageing and sarcopenia, gut integrity, surgical and critical illness recovery, and metabolic resilience, with broader applicability wherever metabolic variation influences patient outcomes and supports earlier diagnosis or treatment decisions.

Alongside his research, Dakshat holds substantial leadership roles across the clinical and analytical science communities. He is the Early Career Research Lead for the NIHR Biomedical Research Centre, shaping strategy, research culture, and development pathways for researchers. Nationally, he chairs the Analytical Science Network (Royal Society of Chemistry). He also contributes to equity and culture initiatives as Communications Lead for the University of Southampton’s Race, Ethnicity and Cultural Heritage (REACH) network.
earch Fellow within the NIHR Biomedical Research Centre (Nutrition, Lifestyle & Metabolism Theme). Trained in Biological Chemistry (PhD, University of Manchester) with degrees in forensic and biomedical sciences, his expertise spans analytical science, chemometrics, and clinical translation.

His research applies advanced mass spectrometry and vibrational spectroscopies to unravel metabolic mechanisms underlying healthy ageing, chronic diseases, and population health. By integrating targeted and untargeted metabolomics with systems biology and other multi-omics approaches, he drives biomarker discovery, metabolic phenotyping, and precision medicine development. His work exemplifies how analytical chemistry and clinical insight can be bridged to achieve translational impact through equitable and personalised health strategies.

Dakshat also serves as Early Career Researcher Lead for the NIHR Southampton BRC, Chair of the Analytical Science Network (UK), and Communications Lead for the University’s REACH Race, Ethnicity & Cultural Heritage Committee. He is passionate about applying metabolomics and analytical science to translate complex metabolic data into meaningful health insights—to empower personalised care, promote equity, and improve outcomes for people everywhere.

Fidele Tugizimana

Fidele Tugizimana

University of Johannesburg
South Africa

Originally from Rwanda (and currently living in South Africa, SA), Fidele Tugizimana holds a Ph.D. in Biochemistry (University of Johannesburg, SA), After the completion of a B.Phil. degree in Philosophy (Urbaniana University, Rome), Fidele Tugizimana enrolled in a B.Sc. Biochemistry-Chemistry degree at the University of Johannesburg; and completed a M.Sc. degree in Biochemistry in 2012. He has received different non-degree purpose training in Advanced Mathematics (UNISA) and in Metabolic modelling, Pathway and Flux analyses (Wageningen University, Netherlands).

Currently, Dr. Fidele Tugizimana is a specialist scientist in the International R&D Management of the Omnia Group Ltd. SA, a research scientist and lecturer in the Department of Biochemistry at the University of Johannesburg, a scientific consultant in the L.E.A.F. Pharmaceuticals LLC (USA & Rwanda). He applies metabolomics approaches in interrogating cellular biochemistry at global level, specifically in plant-environment interactions, plant biostimulants and in the natural products research. His research interests include metabolomics, host-pathogen interactions, immune response (at molecular level). Furthermore, He is involved in driving the implementation of tools and workflows developed and used in extracting information from metabolomics data, exploring 4IR technologies in metabolomics, the use of machine learning and integrated novel computational frameworks (e.g. GNPS) in mining and interpreting metabolomics spectral data.

Dr. Fidele Tugizimana was involved in setting up the metabolomics group at the University of Johannesburg. He is involved in metabolomics training in SA, and had been involved in the establishment of the Metabolomics South Africa (MSA), an affiliate to the Metabolomics Society since June 2018, and he is currently the president of MSA. Dr. Tugizimana is an author/co-author of several metabolomics papers in leading peer-reviewed international scientific journals; and he serves as a guest editor and a reviewer for scientific journals such as Metabolomics, Frontiers in Plant Science, Metabolites, Nature Communications and Scientific Reports.

Candice Z. Ulmer Holland, Ph.D.

Candice Ulmer Holland

USDA-FSIS Eastern Laboratory
USA

  • Society Treasurer – Board of Directors

Dr. Candice Z. Ulmer Holland, a proud native of South Carolina, is the Acting Laboratory Director and Chemistry Branch Chief for the USDA-FSIS Eastern Laboratory. In her current role, she oversees the chemical residue, food chemistry, and nutritional testing of meat, poultry, egg, and Siluriformes products. Dr. Ulmer Holland formally served as the Acting Chief of the Clinical Reference Laboratory for Cancer, Kidney, and Bone Disease Biomarkers in the Clinical Chemistry Branch of the CDC. Her responsibilities included the accurate measurement of chronic disease biomarkers and the assessment of clinical analytical methods in patient care using novel mass spectrometric methodologies and clinical analyzer platforms. Dr. Ulmer Holland possesses B.S. degrees in Chemistry and Biochemistry as well as a Ph.D. in Analytical Chemistry as a McKnight Doctoral Fellow from the University of Florida under the direction of Dr. Richard A. Yost. Dr. Ulmer Holland was also awarded a National Research Council (NRC) post-doctoral research associate appointment with the National Institute of Standards and Technology (NIST) under the direction of Dr. John Bowden. She assumes appointed/elected commitments in scientific organizations such as the American Society for Mass Spectrometry (ASMS), International Metabolomics Society, CLSI Expert Panel on Clinical Chemistry and Toxicology, Metabolomics Quality Assurance and Quality Control Consortium (mQACC) Committee, and the American Chemical Society – GA Division.

Elizabeth Want

Elizabeth Want

Imperial College London
UK

  • Co-Chair – Membership Committee

Dr Elizabeth (Liz) Want is an Associate Professor in Clinical Mass Spectrometry in the Department of Metabolism, Digestion and Reproduction at Imperial College London. She joined Imperial in 2006 after working as a postdoctoral metabolomics researcher at the Scripps Research Institute, La Jolla, CA. Prior to that, she obtained her PhD in Clinical Biochemistry from King’s College London. At Imperial College, she became Lecturer in 2007, Senior Lecturer in 2014 and Head of the Bioanalytical Chemistry Section in 2022. She is Director of the Imperial International Phenome Training Centre, which runs several popular hands-on Metabolomics courses every year.

She has >25 yrs of experience in mass spectrometry and chromatographic techniques and have spent the past 20 years working in the metabolomics field. Her research focuses on the development, optimisation and application of novel liquid chromatography – mass spectrometry (LC-MS) based methodologies for metabolomics. She aims to improve molecular assays for clinical studies, leading to deeper understanding of diseases, improved healthcare and better patient outcomes. She has applied these assays to the analysis of various biological samples, in biomedical areas including cardiovascular disease, glioblastoma, burn injury and pregnancy.

Liz also has a strong interest in teaching and training. She has been the Deputy Director of the MRes in Biomedical Research at Imperial College since 2018. She has mentored multiple BSc, Master’s, Doctoral students and Postdoctoral students. She has given metabolomics courses at International Conferences (ASMS, MSACL).
She is active in the International MSACL committee, the Reid Bioanalytical Forum and is Chair of the London Metabolomics Network.

Aurelia Williams

Aurelia Williams

North-West University
South Africa

  • Chair – Conference Committee

Dr. Aurelia A. Williams is an Associate Professor of Biochemistry at North-West University (NWU), South Africa, and a researcher in the Biomedical and Molecular Metabolism Research Group (BioMMet). Her work focuses on uncovering small-molecule mechanisms underlying infectious and acquired diseases and developing innovative, translational strategies to improve health outcomes.

She completed her undergraduate and master’s studies at the University of Johannesburg and earned her PhD in Biochemistry from the University of Pretoria in 2012, with research on “Metabonomics Profile and Corresponding Immune Parameters of HIV-Infected Individuals.” She later undertook postdoctoral training at the University of California, San Francisco (UCSF), investigating genetic influences on brain tumour metabolism and growth.

Dr. Williams currently serves on the Board of Directors of the International Metabolomics Society, where she is Chair of the Conference Committee and a member of the Membership as well as Education and Training Committees. A prominent leader in South Africa’s scientific community, she is also the Deputy President and co-founder of Metabolomics South Africa (MSA), an organisation dedicated to promoting metabolomics research and collaboration. She chairs MSA’s Training and Conference Committee and previously served as Deputy Secretary (2018–2020).

Dr. Williams is facilitator for the Technological Higher Education Network South Africa (THENSA) under the Department of Science and Innovation, and an active member of several national and international scientific societies.

A passionate advocate for youth and women in science, she actively promotes the participation of young people—especially women—in science, technology, engineering, and mathematics (STEM) disciplines and careers.

Catherine "Cate" Winder

Catherine “Cate” Winder

University of Liverpool
UK

Dr. Catherine “Cate” Winder is a Senior Research Scientist at the University of Liverpool, co-director of the Liverpool Training Centre for Metabolomics and is a member of the Centre for Metabolomics Research. She originally trained as a microbiologist with a BSc (Hons) in Applied Biological Sciences and a PhD investigating antimicrobial resistance in Pseudomonas aeruginosa from the University of Abertay Dundee. She started working in metabolomics in 2001 with post-doctoral roles at the University of Aberystwyth and University of Manchester applying spectroscopy and mass spectrometry-based approaches to explore microbial systems. In 2015 Cate joined the University of Birmingham as Operations Manager of the Birmingham Metabolomics Training Centre and Phenome Centre Birmingham. Cate has worked in the field of metabolomics for > 20 years delivering projects to academic and industry collaborators in both microbial and clinical applications. She is committed to providing training to the metabolomics community has led the development and delivery >15 face-to-face and online metabolomics-based courses and developed the first Massive Open Online Course in metabolomics. Her goals are to train the next generation of metabolomics researchers and support established scientists to apply metabolomics in their research.

 

Thomas Dussarrat

Thomas Dussarrat

Bielefeld University
Germany

  • Treasurer – EMN Committee

Thomas earned a PhD in Cotutelle between the Pontificia Universidad Católica de Chile (Santiago, Chile) and Bordeaux University (Bordeaux, France). During his PhD, he applied a predictive metabolomics approach on multiple species from the Atacama Desert to uncover chemical markers of plant resilience to harsh climates and investigate the ecological and metabolic implications of plant-plant interactions in extreme lands. Currently in postdoc at Bielefeld University in Germany, his research projects combine ecology, metabolomics and machine learning to explore the ecological consequences of intraspecific chemodiversity on plant-herbivore, plant-pollinator and plant-plant interactions. His collaborations with various laboratories in Germany, Chile, France and Switzerland also enable him to study the response and adaptation of plant metabolism to (a)biotic constraints, from metabolites to chemical indices.

Marina Tonetti Botana

Marina Tonetti Botana

Karolinska Institutet
Sweden

Marina is a postdoctoral researcher studying coral reef biology and lipid biochemistry in Craig Wheelock’s lab at Karolinska Institutet (Sweden) in collaboration with Victoria University of Wellington (New Zealand). Her research mainly investigates the role of oxylipins, especially octadecanoids, for the regulation and thermal stability of the symbiotic association between corals and their algal symbionts.

Marina holds a BSc and MSc degree in Oceanography and started working with LC-MS techniques for the characterization of marine lipids during her masters. Originally from Brazil, she is passionate about diversity and integration of different research fields, and about promoting international cooperation between research groups where people learn and grow as a team. As part of the EMN, Marina is looking forward to contributing to more diversity and career opportunities in the metabolomics field.

Carolina Thomaz dos Santos D'Almeida

Carolina Thomaz dos Santos D’Almeida

Center for Innovation in Mass Spectrometry (IMasS-UNIRIO)
Brazil

Carolina is a postdoctoral researcher and associate researcher at the Center for Innovation in Mass Spectrometry (IMasS-UNIRIO), where she integrates metabolomics and in vitro protocols to investigate bioactive compounds in food systems. She holds a PhD in Food Science and Nutrition from UNIRIO (Brazil), with a thesis focused on protein digestibility and the profile and bioaccessibility of phenolic compounds during grain maturation and in sorghum-based products, using foodomics strategies and in silico approaches to explore molecular interactions. Her doctoral work included a research stay at SupAgro Montpellier (France) and an academic mobility period at UNICAMP (Brazil). With over seven years of experience in metabolomics, Carolina has developed expertise in secondary metabolite extraction, UHPLC-MS/MS analysis, and advanced chemometric data interpretation, contributing to innovative approaches for understanding the chemistry of foods. She is also an active member of the French metabolomics and Females in mass spectrometry networks, working to foster international collaboration and promote diversity in science.

Ellen de Paepe

Ellen De Paepe

Ghent University
Belgium

Ellen is a Doctor-Assistant (80%) and Postdoctoral Researcher (20%) at the Laboratory of Integrative Metabolomics (LIMET), Ghent University. Her work focuses on metabolomics in food allergies, overweight and obesity, and exposome research, aiming to identify metabolic pathways that improve our understanding of pediatric diseases, diagnostics, and personalized interventions.

She obtained her Ph.D. in Veterinary Sciences in 2022, using metabolomics and lipidomics to investigate metabolic disturbances underlying cow’s milk allergy in children. Her work combined these approaches with in vivo in murine and in vitro models, as well as microbiome analysis, to explore the link between gut dysbiosis and allergic inflammation.

Currently, Ellen is involved in several large-scale projects, including the first Flemish exposome project FLEXiGUT, the first Flemish Adolescent MEtabolome cohort (FAME), and the ERC-CoG MeMoSA (Metabolomics driven Molecular Source Analysis). 

Her expertise spans (un)targeted metabolomics, lipidomics, microbiome analysis, and biostatistics, with a strong focus on integrating high-resolution mass spectrometry into human health research. She is particularly interested in non-invasive biofluids for metabolomics, offering new opportunities to study metabolic health in children. Through her research, Ellen aims to advance the understanding of pediatric diseases and translate metabolomics findings into clinical applications, ultimately improving early-life metabolic health and disease risk assessment.

Renata Garbellini Duft

Renata Garbellini Duft

Rowett Institute at the University of Aberdeen
Scotland

Renata is a postdoctoral research fellow at the Rowett Institute at the University of Aberdeen in Scotland. Her research is funded by the Scottish Government and focuses on developing metabolomics and proteomics tools for food provenance and authenticity. She has an academic background in exercise science and holds an MSc and a PhD from the Universidade Estadual de Campinas in Brazil, funded by FAPESP fellowship. During her doctoral research, she applied an LC-MS lipidomic approach to investigate the effects of exercise on lipid metabolism in individuals with obesity and type 2 diabetes. In 2021, she joined Imperial College London as a visiting PhD researcher under the supervision of Professor Jules Griffin, who now supervises her postdoctoral research.

Originally trained as a teacher, Renata is committed to education and mentorship, actively mentoring undergraduate, master’s, and PhD students. She also enjoys communicating science in creative and accessible ways, engaging the public through scientific outreach initiatives and events. Her research interests include metabolomics, lipidomics and proteomics, as well as their applications in the fields of nutrition, food safety, exercise science, and metabolic diseases.

Maria Llambrich

Maria Llambrich

Health Research Institute Pere Virgili
Reus, Spain

Maria Llambrich is a bioinformatician and statistician at the Health Research Institute Pere Virgili (Reus, Spain). She earned her PhD in 2025 at the Universitat Rovira i Virgili (URV) with the thesis “Innovative tools and strategies for metabolomics data analysis”. With a background in Biochemistry and Molecular Biology and an MSc in Omics Data Analysis. Her research focuses on advanced metabolomics applied to colorectal cancer, with expertise in gas chromatography–mass spectrometry (GC–MS) and data analysis. Currently, she is transitioning her career toward in vitro diagnostic (IVD) development, with the overarching goal of creating innovative tools that transform omics data into meaningful biomedical insights.

Shauni Loopmans

Shauni Loopmans

Laboratory of Applied Mass Spectrometry at KU Leuven
Belgium

Shauni is a postdoctoral researcher in the Laboratory of Applied Mass Spectrometry at KU Leuven, Belgium. She holds a Master’s degree in Bioscience Engineering, and her doctoral work centered on characterizing skeletal cell metabolism during bone development with applications in bone tissue engineering. Her current research investigates metabolic alterations underlying obesity-induced heart failure. Alongside her academic role, she contributes as a consulting scientist at the VIB Metabolomics Core Leuven, where she supports clients in designing (tracer) metabolomics experiments and provides biological interpretation of metabolomics data.

Juan José Oropeza Valdez

Juan José Oropeza Valdez

Human Systems Biology-INMEGEN
Mexico

Juan José is currently a Postdoctoral Fellow at the Center for Complexity Sciences, Universidad Nacional Autónoma de México, where he works in the Human Systems Biology Laboratory under the guidance of Dr. Osbaldo Resendis Antonio. He is currently doing research that utilizes artificial intelligence to analyze microbiota and metabolomic data, aiming to unravel the complex interactions between host systems and microbial communities, thereby developing innovative diagnostic and therapeutic strategies in personalized medicine.

During his Ph.D. in Biomedical Sciences at the Autonomous University of San Luis Potosí, his research focused on using metabolomics to identify new biomarkers for the progression of diabetic nephropathy. He also holds a Master’s in Basic Biomedical Sciences from the same institution and a Bachelor’s in Pharmaceutical Chemistry and Biology from the Autonomous University of Zacatecas. Additionally, he has been working on both targeted and untargeted metabolomic approaches to characterize metabolic alterations in COVID-19 and post-COVID-19.

Luciana Ribeiro da Silva Lima

Luciana Ribeiro da Silva Lima

Federal University of the State of Rio de Janeiro (UNIRIO)
Brazil

Luciana is a final-year PhD student at the Graduate Program in Food Science and Nutrition at the Federal University of the State of Rio de Janeiro (UNIRIO), Brazil. Her research focuses on the application of LC-MS-based metabolomics in investigating the impacts of food processing on the specialized metabolites in major and minor cereal grains. She is also working with bioinformatics tools to study the biotransformation of these metabolites during static in vitro digestion on grain samples.

She holds an MSc in Food and Nutrition and a BSc in Nutrition from the same university (UNIRIO) and a PhD mobility at the University of Granada (Spain). She is passionate about research, promoting learning opportunities, and scientific communication to make science an easy and popular subject.

Nicholas J.W. Rattray

Nicholas J. W. Rattray

University of Strathclyde
UK

  • Chair – Education & Training Committee

Nicholas (Nik) Rattray is Professor of Clinical Metabolism at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where he also serves as Director of the Strathclyde Centre for Molecular Bioscience. He earned his PhD in Biophysics from the University of Manchester and completed postdoctoral research at the Manchester Institute of Biotechnology, applying mass spectrometry-based metabolomics to investigate the biochemistry of frailty. He later held a faculty-level Associate Research Scientist position at the Yale School of Public Health, focusing on metabolomics in large-scale population studies. He currently holds a Royal Society Industry Fellowship on Surgical Frailty and is a Fellow of the Higher Education Academy.

Nik’s research group at Strathclyde explores how metabolic pathways become dysregulated with age, with a particular emphasis on predictive metabolic and protein biomarkers of surgical response. His research is structured around three interconnected themes:

  • Biomolecular Target Development: Employing advanced metabolomics, proteomics, stable isotope tracers, and cell-based assays to identify biomarkers associated with senescence, age-related diseases, and frailty.
  • Clinical Translation: Designing and conducting clinical trials to assess mitochondrial biomarkers as predictors of surgical outcomes in frail and diseased patients.
  • Biobank-Driven Insights: Applying AI and deep learning to multiomics datasets (e.g., UK Biobank) to examine how biomolecular, clinical, and socioeconomic factors interact in the context of frailty.

This multidisciplinary approach is also being applied to diseases such as breast cancer, colon cancer, oropharyngeal cancer, and inflammatory bowel disease. Nik’s overarching goal is to define the biomolecular basis of ageing and establish global leadership in the metabolism of frailty, transforming clinical and societal perspectives on ageing through translational science.

Millena Barros Santos

Millena Barros Santos

INRAE Avignon
France
Email

  • Co-Chair – Diversity, Equity, and Inclusion Task Group
  • Treasurer – EMN Committee

Millena Barros Santos is a junior research scientist in the UMR SQPOV – Safety and Quality of Products of Plant Origin at INRAE (the French National Research Institute for Agricultural and Environmental Research) in Avignon, France. Her research projects involve applying metabolomics to explore the evolution of phytoconstituents during the production-storage-processing-consumption-digestion continuum, hierarchising the reactivity factors and key stages in the transformation and digestion of fruits and vegetables and predicting product nutritional quality.

She holds a Ph.D. in Food and Nutrition (Food Science Area), from the Food and Nutrition Graduate Program (PPGAN) at the Federal University of the State of Rio de Janeiro (UNIRIO) in Brazil, supported by a CAPES scholarship. During her thesis, she had the opportunity to conduct untargeted metabolomic analyses of various food matrices through collaborations with Brazilian and international laboratories and to follow an internship with a Brazilian scholarship (FAPERJ) at INRAE, Institut SupAgro, and CIRAD in Montpellier, France. She was a Postdoctoral Researcher at the Bordeaux Metabolome-MetaboHUB (INRAE Bordeaux Nouvelle-Aquitaine) in France, applying mass spectrometry-based metabolomics to study large plant cohorts and elucidate associations between the metabolome and agronomical traits through predictive metabolomics.

Millena is co-chair of the Diversity, Equity, and Inclusion (DEI) Task Group of the Society, and she is on the Committee of the Portal Metabolômica Brasil. She has previously served on the Early-career Members Network (EMN) Committee and treasurer 2022-2024.

Domenica Berardi

Domenica Berardi

Yale University
USA
Email

  • Co-Chair – Diversity, Equity, and Inclusion Task Group

Domenica Berardi is a Postdoctoral researcher at the Department of Public Health at Yale University (USA) where she is using metabolomics to simultaneously analyze the effects of exposures, their changes to the endogenous metabolome and biological impact for cancer development and progression. She holds a PhD in Pharmacy and Biomedical Science from the University of Strathclyde (Glasgow, UK) where her research focused on the investigation of Aging and the assessment of the metabolic changes associated with its physiological and degenerative processes. Her interest in metabolomics started during her master’s degree at the University of Pavia (Italy) where she studied the effect of Glucose and Glutamine metabolism for Breast Cancer cells proliferation and oncogene expression. This research was further explored at the Institute of Genetics and Cancer of Edinburgh (UK) through the application of LC-MS/MS technologies. In 2019 she became a member of the Metabolomics Society, which gave her the opportunity to broaden her scientific and networking skills in the field of metabolomics. She joined the EMN society with the idea of transmitting the opportunities received to the younger scientists, and supporting the scientific progression in the field of metabolomics.

Koel Chaudhury

Koel Chaudhury

Indian Institute Of Technology Kharagpur
India

Marvin Nathanael Iman

Marvin Nathanael Iman

Pharma Foods International Co., Ltd.
Japan

Marvin is a research associate at Osaka University, Japan. His research explores the multidisciplinary bridging of food metabolomics and molecular epidemiology to better understand foods’ health benefits.

Caroline Johnson

Caroline Johnson

Yale School of Public Health
USA

Dr. Caroline Johnson is an Assistant Professor of Epidemiology and Metabolomics in the Department of Environmental Health Sciences at Yale School of Public Health (YSPH). In 2009, she graduated from Imperial College London with a PhD in Analytical Chemistry under the mentorship of Profs. Jeremy Nicholson, John Lindon and Ian Wilson, where she studied the role of reactive drug metabolites in relation to toxicity. She then held a postdoctoral appointment at the National Cancer Institute, NIH, in Dr. Frank Gonzalez’s lab and examined the biological effects of ionizing radiation and dietary exposures on human health using metabolomics. From 2012-2016 she directed the cancer metabolism efforts at the Scripps Research Center for Metabolomics with Prof. Gary Siuzdak’s lab where she was involved in the optimization of XCMS Online and METLIN technologies.

Since joining YSPH in 2016, her lab’s primary focus has been to develop metabolomics for epidemiologic and population-level analysis. The lab is also using mass spectrometry imaging approaches to better understand tissue metabolite heterogeneity and the link between metabolites and cellular pathology. The lab is currently investigating the relationship between genetic and environmental influences in women with colon cancer, and the examination of early-life exposures in pregnancy outcomes. Dr. Johnson also serves on the editorial boards for Metabolites, Toxicological Sciences and Frontiers in Immunology and Nutrition.

Daniela Ramirez

Daniela Andrea Ramirez

CONICET-UNCuyo
Argentina

Dr. Daniela Ramirez is a post-doc researcher at the National Scientific and Technical Research Council of Argentina (CONICET), currently developing her work at the Instituto de Biología Agrícola de Mendoza (IBAM). She is also a teaching assistant working in the Analytical Chemistry Department of the Agronomic Faculty of the Cuyo National University (UNCuyo – Mendoza, Argentina). She has a PhD in Science and Technology, specialized in functional foods’ study, chemometrics, including QSAR studies (quantitative structure-activity relationship), and analytical techniques development. Current research interests are focused on showing metabolomics studies’ versatility in terms of food science and nutrition, studying phytochemicals not only as bioactive compounds effective in nutraceutical intervention studies, but also as authenticity markers to define quality and safety attributes in functional horticultural products, using LC-MS/MS techniques.

Since 2023, she has been an active member of the Early Career Members Network (EMN) from the Metabolomics Society, serving in different task groups (Webinar TG, Conference), and she is the TG leader of the Networking and Recruitment TG. She is also associated with other MS and metabolomics-related societies and affiliations, including LAMPS and SAEM (Argentina).

Generic Person Place Holder

Lungile Sitole

Dr. Lungile Sitole is Senior Lecturer in the Department of Integrative Biomedical Sciences in the Division of Medical Biochemistry at the University of Cape Town. She holds both a Bachelors (Magna Cum Laude) and Master’s (Cum Laude) degree in Organic Chemistry from Jackson State University (MS, USA) as well as a PhD in Biochemistry from the University of Pretoria and a Master of Public Health (MPH) from the University of Johannesburg. She is a DST Women in Science alumni who was featured in the Mail & Guardian Top 200 young South Africans (2015). She is also a Golden Key International Honours Society member as well as an ambassador for South Africa’s 2017 National Development Plan (NDP 2030). Sitole is an alumnus of both the UJ Women’s Leadership Development Programme (UJWLDP) as well as the Women in Research Leadership. Dr. Sitole’s current research focus is on the application of metabolomics techniques for cancer prognostic purposes, specifically screening of treatment-response markers as well as discovery of drug targets.

Laimdota Zizmare

Laimdota Zizmare

Eberhard Karls University of Tuebingen
Germany

Dr. Laimdota Zizmare obtained her PhD in Pharmacy, Metabolomics & Systems Medicine in 2023 at the Eberhard Karls University of Tuebingen and University Hospital Tuebingen, Germany. Her scientific interests include pre-clinical and clinical immuno-oncology, metabolic diseases, neurological conditions, and public health policy initiatives. Her technical expertise comprises NMR spectroscopy, mass spectrometry, and MALDI imaging MS applications for metabolomics and multi-omics research, biomarker discovery and validation.

Laimdota previously served as the early-career member network (EMN) committee member and treasurer 2021-2023. She holds a Master of Science in Medicinal Chemistry and Physical Sciences for Health from the University of Birmingham, United Kingdom, and a Bachelor of Chemical Engineering from Riga Technical University, Latvia, highlighting her passion for STEM and international collaboration.

Masanori Arita

Masanori Arita

National Institute of Genetics
RIKEN Center for Sustainable Resource Science
Japan

  • Deputy Chair – Publications Committee

Masanori Arita (MA) began working in metabolomics around 2005, when the first meeting of the metabolomics society was held in Tsuruoka City, Japan, hosted by Masaru Tomita (Keio University). Following the meeting, the MassBank project was launched in Tsuruoka, where I contributed as both a programmer and an MS/MS fragmentation analyst. MassBank developed alongside the community, with its first publication in 2010.

In 2011, I began a formal collaboration with Prof. Oliver Fiehn (UC Davis) on algal biofuel, supported by JST and NSF. This project led to several key outcomes, including MassBank of North America (MoNA), the SPLASH identifier for mass spectra, and the MS-DIAL software. The project continued until March 2017.

During this period, I was appointed Professor at the National Institute of Genetics, Japan. In 2018, I became Head of the DNA Data Bank of Japan (DDBJ), one of the three nodes in the International Nucleotide Sequence Database Collaboration (INSDC). Since then, my primary focus had to shift to all omics. In 2019, the MassBank project was transferred to the Mass Spectrometry Society of Japan (MSSJ). Around the same time, I initiated MetaboBank, a public repository for raw metabolomics and lipidomics data, developed under the INSDC framework.

Lynn Vanhaecke

Lynn Vanhaecke

Ghent University
Belgium

  • Chair – Website & Communication Committee

Lynn Vanhaecke is a Professor at the Laboratory of Integrative Metabolomics (LIMET) at Ghent University, Belgium since 2011 with a 20% appointment at the Institute of Global Food Security at Queen’s University Belfast, UK since 2018. She holds a Ph.D. in Bioscience Engineering (2008) on gut microbial food metabolism. 

Her team has specific expertise in optimizing and validating high-resolution mass spectrometry (HRMS)-based metabolomics and lipidomics methods with a focus on gastrointestinal matrices (saliva, stool, in vitro digests) and uses the latter to explore metabolic pathways of food- and gut microbiome-related diseases ranging from food allergies to obesity and its comorbidities. She is also particularly interested in the application of ambient ionization-based HRMS (specifically REIMS) for biofluid and food metabolomics and invented the MetaSamp® biofluid sampler in this context. 

Lynn’s lab has pioneered the field of DNA adductomics in the EU by developing a high-end analytical UHPLC-HRMS platform for untargeted DNA adduct measurements. In recent years, her lab has also gained an interest in the computational part of the metabolomics workflow with dedicated bioinformaticians on staff. Lynn is coordinator of the core facility on small molecule analysis (MSsmall) at Ghent University and a board member of the Nutrigenomics Society (NuGO). 

She was involved in the Horizon 2020 JPI-HDHL Foodball project and two EIT Food projects on food metabolomics and is now a core partner of the first Flemish Exposome project (Flexigut). LIMET’s metabolomics workflows have been sublicensed to Prodigest under the brand name MetaKey® for commercial application.

Laneke Luies

Laneke Luies

Biomedical Molecular and Metabolism Research Group (BioMMet), South Africa